Publication | Open Access
Efficacy and Safety of a Novel Botulinum Toxin Type A Product for the Treatment of Moderate to Severe Glabellar Lines: A Randomized, Double-Blind, Active-Controlled Multicenter Study
32
Citations
13
References
2013
Year
NBoNT is equally as effective as OBoNT for the treatment of glabellar frown lines. Both toxins were well tolerated.
| Year | Citations | |
|---|---|---|
Page 1
Page 1